Javascript must be enabled to continue!
Data from Jun Proteins Are Starvation-Regulated Inhibitors of Autophagy
View through CrossRef
<div>Abstract<p>The growing number of biological functions affected by autophagy ascribes a special significance to identification of factors regulating it. The activator protein-1 (AP-1) transcription factors are involved in most aspects of cellular proliferation, death, or survival, yet no information regarding their involvement in autophagy is available. Here, we show that the AP-1 proteins JunB and c-Jun, but not JunD, c-Fos, or Fra-1, inhibit autophagy. JunB inhibits autophagy induced by starvation, overexpression of a short form of ARF (smARF), a potent inducer of autophagy, or even after rapamycin treatment. In agreement, acute repression of JunB expression, by JunB knockdown, potently induces autophagy. As expected from autophagy-inhibiting proteins, Jun B and c-Jun expression is reduced by starvation. Decrease in JunB mRNA expression and posttranscriptional events downregulate JunB protein expression after starvation. The inhibition of autophagy by JunB is not mediated by mammalian target of rapamycin (mTOR) regulation, as it occurs also in the absence of mTOR activity, and autophagy induced by JunB knockdown is not correlated with changes in mTOR activity. Nevertheless, the transcriptional activities of c-Jun and JunB are required for autophagy inhibition, and JunB incapable of heterodimerizing is a less effective inhibitor of autophagy. Most importantly, inhibition of autophagy in starved HeLa cells by JunB enhances apoptotic cell death. We suggest that JunB and c-Jun are regulators of autophagy whose expression responds to autophagy-inducing signals. Cancer Res; 70(6); 2318–27</p></div>
American Association for Cancer Research (AACR)
Title: Data from Jun Proteins Are Starvation-Regulated Inhibitors of Autophagy
Description:
<div>Abstract<p>The growing number of biological functions affected by autophagy ascribes a special significance to identification of factors regulating it.
The activator protein-1 (AP-1) transcription factors are involved in most aspects of cellular proliferation, death, or survival, yet no information regarding their involvement in autophagy is available.
Here, we show that the AP-1 proteins JunB and c-Jun, but not JunD, c-Fos, or Fra-1, inhibit autophagy.
JunB inhibits autophagy induced by starvation, overexpression of a short form of ARF (smARF), a potent inducer of autophagy, or even after rapamycin treatment.
In agreement, acute repression of JunB expression, by JunB knockdown, potently induces autophagy.
As expected from autophagy-inhibiting proteins, Jun B and c-Jun expression is reduced by starvation.
Decrease in JunB mRNA expression and posttranscriptional events downregulate JunB protein expression after starvation.
The inhibition of autophagy by JunB is not mediated by mammalian target of rapamycin (mTOR) regulation, as it occurs also in the absence of mTOR activity, and autophagy induced by JunB knockdown is not correlated with changes in mTOR activity.
Nevertheless, the transcriptional activities of c-Jun and JunB are required for autophagy inhibition, and JunB incapable of heterodimerizing is a less effective inhibitor of autophagy.
Most importantly, inhibition of autophagy in starved HeLa cells by JunB enhances apoptotic cell death.
We suggest that JunB and c-Jun are regulators of autophagy whose expression responds to autophagy-inducing signals.
Cancer Res; 70(6); 2318–27</p></div>.
Related Results
Data from Jun Proteins Are Starvation-Regulated Inhibitors of Autophagy
Data from Jun Proteins Are Starvation-Regulated Inhibitors of Autophagy
<div>Abstract<p>The growing number of biological functions affected by autophagy ascribes a special significance to identification of factors regulating it. The activat...
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract 1674: Inhibition of GSK3 reduces p70S6K activity and promotes autophagy independently of the JNK-cJun pathway.
Abstract
Considering that a tumor promoting role for GSK3 has been suggested in pancreatic cancer (PC) cells and that GSK3 inhibitors are currently under clinical tr...
Abstract 1688: Autophagy inhibition enhances the antitumor effects of combretastatin A4 phosphate (CA4P).
Abstract 1688: Autophagy inhibition enhances the antitumor effects of combretastatin A4 phosphate (CA4P).
Abstract
Vascular disruptive agents such as CA4P cause an acute shutdown of the tumor vasculature resulting in metabolic stress and central tumor necrosis. However, ...
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
<div>Abstract<p>Autophagy is a mechanism by which cells degrade cellular material to provide nutrients and energy for survival during stress. The autophagy is thought t...
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
Data from Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
<div>Abstract<p>Autophagy is a mechanism by which cells degrade cellular material to provide nutrients and energy for survival during stress. The autophagy is thought t...
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract 2271: Autophagy induction by low dose cisplatin: The role of p53 in autophagy
Abstract
Cisplatin has been mainly used for lung-cancer. However, cisplatin has many side effects, so the usage of cisplatin has a limitation. Recently, autophagy ha...
Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
Targeting Autophagy As a Therapeutic Strategy in Acute Myeloid Leukemia
Abstract
Introduction: Autophagy is a process whereby cells digest their own organelles in conditions of stress, such as low nutrient concentration, hypoxia or expos...
Data from Targeting Autophagy Augments <i>In Vitro</i> and <i>In Vivo</i> Antimyeloma Activity of DNA-Damaging Chemotherapy
Data from Targeting Autophagy Augments <i>In Vitro</i> and <i>In Vivo</i> Antimyeloma Activity of DNA-Damaging Chemotherapy
<div>Abstract<p><b>Purpose:</b> Although autophagy occurs in most tumor cells following DNA damage, it is still a mystery how this DNA-damaging event turns ...

